CDC25A and breast cancer: However, neither overexpression of cyclin D1 or of cdc25A was found to be an independent indicator of prognosis in early stage breast cancer (Michalides et al, 1996; Van Diest et al, 1997; Cangi et al, 2000; Leong et al, 2000).